Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Peginterferon Plus Ribavirin Versus Interferon Plus Ribavirin for Chronic Hepatitis C: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437123/1/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension_New. Accessed 25 April 2024.
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437123/1/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension_New. Accessed April 25, 2024.
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437123/1/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension_New
Peginterferon Plus Ribavirin Versus Interferon Plus Ribavirin for Chronic Hepatitis C: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437123/1/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C: Cochrane systematic review
ID - 437123
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437123/1/Anticoagulation_therapy_versus_placebo_for_pulmonary_hypertension_New
DB - Evidence Central
DP - Unbound Medicine
ER -